• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 249-263 of 901 results

1024 Exhibit: 1024 Drucker, The Incretin System Glucagon Like Peptide 1 Recepto...

Document IPR2024-00631, No. 1024 Exhibit - 1024 Drucker, The Incretin System Glucagon Like Peptide 1 Receptor Agonist (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1034 Exhibit: 1034 US Patent No 6,268,343

Document IPR2024-00631, No. 1034 Exhibit - 1034 US Patent No 6,268,343 (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1003 Exhibit: 1003 Bantle Declaration

Document IPR2024-00631, No. 1003 Exhibit - 1003 Bantle Declaration (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1011 Exhibit: 1011 WO 2011138421

Document IPR2024-00631, No. 1011 Exhibit - 1011 WO 2011138421 (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1069 Exhibit: 1069 REMINGTON THE SCIENCE AND PRACTICE OF PHARMACY A...

Document IPR2024-00631, No. 1069 Exhibit - 1069 REMINGTON THE SCIENCE AND PRACTICE OF PHARMACY Alfonso R Gennaro ed (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1081 Exhibit: 1081 Ozempic prescribing information Oct 2022

Document IPR2024-00631, No. 1081 Exhibit - 1081 Ozempic prescribing information Oct 2022 (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1008 Exhibit: 1008 CV of Paul Dalby, PhD

Document IPR2024-00631, No. 1008 Exhibit - 1008 CV of Paul Dalby, PhD (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1013 Exhibit: 1013 Clinical Trial No NCT00696657

Document IPR2024-00631, No. 1013 Exhibit - 1013 Clinical Trial No NCT00696657 (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1045 Exhibit: 1045 Shargel, APPLIED BIOPHARMACEUTICS PHARMACOKINETIC...

Document IPR2024-00631, No. 1045 Exhibit - 1045 Shargel, APPLIED BIOPHARMACEUTICS PHARMACOKINETICS 5th ed 2005 (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1504 Exhibit: 1504 CV of Mark J Ratain, MD

Document IPR2024-00631, No. 1504 Exhibit - 1504 CV of Mark J Ratain, MD (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1087 Exhibit: 1087 Prosecution history excerpts for US Patent No 9,764,003

Document IPR2024-00631, No. 1087 Exhibit - 1087 Prosecution history excerpts for US Patent No 9,764,003 (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1032 Exhibit: 1032 Knudsen, Glucagon like Peptide 1 The Basis of a New Class of T...

Document IPR2024-00631, No. 1032 Exhibit - 1032 Knudsen, Glucagon like Peptide 1 The Basis of a New Class of Treatmen (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1033 Exhibit: 1033 Knudsen, Liraglutide, a GLP­1 Analogue to Treat Diabetes, in A...

Document IPR2024-00631, No. 1033 Exhibit - 1033 Knudsen, Liraglutide, a GLP­1 Analogue to Treat Diabetes, in ANALOGUE (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1503 Exhibit: 1503 Declaration of Mark J Ratain, MD

Document IPR2024-00631, No. 1503 Exhibit - 1503 Declaration of Mark J Ratain, MD (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1016 Exhibit: 1016 US Patent Application Pub No US20070010424

Document IPR2024-00631, No. 1016 Exhibit - 1016 US Patent Application Pub No US20070010424 (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 17 18 19 20 21 ... >>